Singapore markets open in 5 hours 37 minutes
Straits Times Index
3,322.08 -8.69 (-0.26%) S&P 500
5,361.86 +14.87 (+0.28%) Dow
38,841.13 +42.14 (+0.11%) Nasdaq
17,201.07 +67.95 (+0.40%) Bitcoin USD
69,622.35 -173.84 (-0.25%) CMC Crypto 200
1,445.94 -0.73 (-0.05%)
PRTA Jan 2026 17.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:38PM EDT. Market open.
| Previous close | 4.7000 |
| Open | 4.8700 |
| Bid | 3.5000 |
| Ask | 5.2000 |
| Strike | 17.50 |
| Expiry date | 2026-01-16 |
| Day's range | 4.7000 - 4.8700 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
ZacksBiogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
FDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of Alzheimer's drug Leqembi. The final FDA decision is expected on Jan 25, 2025.
ZacksWhy Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksProthena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.
© 2024 Yahoo. All rights reserved.